Solriamfetol for treating excessive daytime sleepiness caused by obstructive sleep apnoea

Supporting evidence

• Evaluation report

• Appraisal consultation committee papers (PDF 3.47 MB)

  Published:

  09 March 2022

• Final appraisal determination committee papers (PDF 1.56 MB)

  Published:

  09 March 2022